WILLIAM CLAYTOR: Open Payments
NPI 1023424587 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 96 payments from 22 companies in 2025. Trend: 2023 $2,232 · 2024 $2,416 · 2025 $2,024
Food & beverage: $2,024
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $297 |
| PFIZER INC. | 14 | $246 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $234 |
| AstraZeneca Pharmaceuticals LP | 10 | $232 |
| Novo Nordisk Inc | 11 | $172 |
| Abbott Laboratories | 7 | $146 |
| ABBVIE INC. | 6 | $125 |
| Phathom Pharmaceuticals, Inc. | 2 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Astellas Pharma US Inc | 3 | $60 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, AIRSUPRA, VOQUEZNA, UBRELVY, ELIQUIS, ZEPBOUND, FARXIGA.
Industry payments across FL — which companies pay providers there.
